Clinical trial

Investigational Device Exemption (IDE) Study for the Approval of Closed Loop…

NCT00356057 · Biotronik, Inc., Industry · Terminated

Key facts

NCT number NCT00356057
Title Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace
Official title AVAIL CLS/CRT: AV-node Ablation With CLS and CRT Pacing Therapies for the Treatment of AF
Acronym AVAIL
Lead sponsor Biotronik, Inc., Industry
Status Terminated
Study type Interventional
Conditions Atrial Fibrillation, Congestive Heart Failure
Intervention type Device
Interventions Protos DR/CLS and Stratos LV CRT pacemakers
Enrollment 153
Start date Dec 1, 2004
Primary completion May 1, 2008
Completion Jun 1, 2008
First posted Jul 25, 2006
Last update posted Feb 27, 2018
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies